Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer-Reference-Cited by-同舟云学术

Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer

Published:2017-03-14 Issue:4 Volume:109 Page:
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Kim Kelly Y.,Le Quynh-Thu,Yom Sue S.,Pinsky Benjamin A.,Bratman Scott V.,Ng Raymond H. W.,El Mubarak Haja S.,Chan K. C. Allen,Sander Miriam,Conley Barbara A.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/109/4/djx007/17272139/djx007.pdf

Reference35 articles.

1. Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992–2002;Am J Epidemiol.,2005

2. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men;N Engl J Med.,2001

3. Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan;Cancer Epidemiol Biomarkers Prev.,2014

4. The role of Epstein-Barr virus DNA load and serology as screening tools for nasopharyngeal carcinoma;Otolaryngol Head Neck Surg.,2016

5. Diagnostic value of serum EBV-DNA quantification and antibody to viral capsid antigen in nasopharyngeal carcinoma patients;Cancer Sci.,2004

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From the midfacial destructive drama to the unfolding EBV story: a short history of EBV-positive NK-cell and T-cell lymphoproliferative diseases;Pathology;2024-10

2. 5-Hydroxymethylcytosines in circulating cell-free DNA as a diagnostic biomarker for nasopharyngeal carcinoma;European Journal of Cancer;2024-10

3. Clinical significance of serum lactate dehydrogenase combined with a multivariate model for predicting the near-term outcome of primary nasopharyngeal carcinoma;Life Sciences;2024-08

4. Pan‑immune‑inflammation value as a novel prognostic biomarker in nasopharyngeal carcinoma;Oncology Letters;2024-04-09

5. Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders;Cancers;2024-01-16